Altis has been a clinical research company providing high-quality services, guidance, and comprehensive solutions in licensing for the pharmaceutical and biomedical industries since 2001. Our expertise covers a wide range, including Phase 1, Phase 2, Phase 3, and Phase 4 clinical trials, observational studies, licensing, and clinical research training. Altis CRO is approved by the Turkish Ministry of Health, General Directorate of Pharmaceuticals and Pharmacy as a contract research organization operating within the framework of relevant regulations and in accordance with the "Good Clinical Practice Guidelines" for conducting clinical research.